Reduced neuronotrophic activity of fibroblasts from individuals with dysautonomia in cultures of newborn mouse sensory ganglion cells - PubMed (original) (raw)
Comparative Study
. 1986 Jan 29;364(1):23-9.
doi: 10.1016/0006-8993(86)90983-2.
- PMID: 3947964
- DOI: 10.1016/0006-8993(86)90983-2
Free article
Comparative Study
Reduced neuronotrophic activity of fibroblasts from individuals with dysautonomia in cultures of newborn mouse sensory ganglion cells
J R Wrathall. Brain Res. 1986.
Free article
Abstract
The neuronotrophic activity of human skin fibroblast cell lines from two normal individuals and 3 individuals with Familial Dysautonomia (FD) was compared in terms of their ability to support neuron survival and neurite regeneration in cultures of newborn mouse sensory neurons. Neuronotrophic activity was assayed by culturing dissociated sensory neurons from newborn mice: (1) on fibroblast 'cell beds' consisting of monolayer cultures of living fibroblasts, (2) with medium that had been conditioned by monolayer fibroblast cultures and (3) with extracts of the cultured fibroblasts. Neurite regeneration was compared by determining the percentage of neurons that had regenerated neurites after 24 or 48 h in culture. Neuron survival was determined by counts at 48 h, 7 days and 14 days after culture initiation. Neurite regeneration and neuron survival was found to be significantly less on FD cell beds or with FD-conditioned medium than in replicate cultures with normal fibroblasts or their conditioned medium. The reduced neuronotrophic activity of FD fibroblasts or conditioned medium was still observed in the presence of antibody sufficient to block the neuronotrophic effects of purified nerve growth factor (NGF). Thus, fibroblasts from individuals with FD exhibit reduced neuronotrophic activity for newborn mouse sensory neurons that appears to be due to factor(s) other than NGF.
Similar articles
- Growth factor interactions in cultures of dissociated adult acoustic ganglia: neuronotrophic effects.
Lefebvre PP, Van de Water TR, Weber T, Rogister B, Moonen G. Lefebvre PP, et al. Brain Res. 1991 Dec 20;567(2):306-12. doi: 10.1016/0006-8993(91)90809-a. Brain Res. 1991. PMID: 1817733 - Cerebellar macroneurons in serum-free cultures: evidence for intrinsic neuronotrophic and neuronotoxic activities.
Grau-Wagemans MP, Selak I, Lefebvre PP, Moonen G. Grau-Wagemans MP, et al. Brain Res. 1984 Jul;317(1):11-9. doi: 10.1016/0165-3806(84)90135-4. Brain Res. 1984. PMID: 6467025 - Familial dysautonomia (a brief review).
Pearson J. Pearson J. J Auton Nerv Syst. 1979 Dec;1(2):119-26. doi: 10.1016/0165-1838(79)90010-9. J Auton Nerv Syst. 1979. PMID: 399775 Review. No abstract available. - Nerve growth factor.
Siggers DC. Siggers DC. Dev Med Child Neurol. 1976 Oct;18(5):668-9. doi: 10.1111/j.1469-8749.1976.tb04215.x. Dev Med Child Neurol. 1976. PMID: 789161 Review. No abstract available.
Cited by
- Familial Dysautonomia: Mechanisms and Models.
Dietrich P, Dragatsis I. Dietrich P, et al. Genet Mol Biol. 2016 Oct-Dec;39(4):497-514. doi: 10.1590/1678-4685-GMB-2015-0335. Epub 2016 Aug 4. Genet Mol Biol. 2016. PMID: 27561110 Free PMC article. - Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31.
Blumenfeld A, Slaugenhaupt SA, Liebert CB, Temper V, Maayan C, Gill S, Lucente DE, Idelson M, MacCormack K, Monahan MA, Mull J, Leyne M, Mendillo M, Schiripo T, Mishori E, Breakefield X, Axelrod FB, Gusella JF. Blumenfeld A, et al. Am J Hum Genet. 1999 Apr;64(4):1110-8. doi: 10.1086/302339. Am J Hum Genet. 1999. PMID: 10090896 Free PMC article. - Increased globotriaosylceramide in familial dysautonomia.
Strasberg P, Yeger H, Warren I. Strasberg P, et al. Lipids. 1992 Dec;27(12):978-83. doi: 10.1007/BF02535575. Lipids. 1992. PMID: 1336803